COIOSDeep risk insights through multi-disciplinary research across the globe
text
Item new Peer-reviewed Added

Fewer than one in five US stroke and TIA patients filled a P2Y12 inhibitor

Among 45,763 US adults with a first ischaemic stroke or TIA, 18.9% filled a P2Y12 inhibitor within 30 days, and half of clopidogrel initiators had stopped filling by 180 days.

A US claims study described prescription filling after a first ischaemic stroke or TIA in 45,763 adults between July 2020 and December 2024. Fewer than one in five filled a P2Y12 inhibitor within 30 days, and 94.9% of those fills were clopidogrel. Among 5641 continuously enrolled initiators, persistence at 180 days was 50.5% for clopidogrel as compared to 59.6% for ticagrelor.

Why it is interesting: Benchmarks what was actually acquired and continued in routine care, not guideline adherence or comparative effectiveness.

Source
Annals of Pharmacotherapy, 1 October 2026
Paper
Real-World Postdischarge P2Y12 Inhibitor Use After Ischemic Stroke and Transient Ischemic Attack, 2020 to 2024
Authors
Qureshi AI, Raza H, Tolba H, Kaur G, Pfeiffer K, Sandifer T et al.
DOI
10.1177/10600280261487728
Type
Peer-reviewed article
Design
Retrospective descriptive cohort, US claims 2020-2025, 45 763 adults with first ischaemic stroke or TIA; persistence assessed in 5641 continuously enrolled initiators
Verdict
New finding
Driver
Adherence and persistence
Free full text
Free to read at the publisher

Other drivers in Behavioural science